NCT05062460View on ClinicalTrials.gov

Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

June 1, 2024

Study Completion Date

May 1, 2025

Conditions
Gestational Diabetes
Interventions
OTHER

1 hour Blood glucose monitoring

Consented patients who are diagnosed with gestational diabetes will be randomized to 1-hour postprandial blood glucose monitoring.

OTHER

2 hour blood glucose monitoring

Consented patients who are diagnosed with gestational diabetes will be randomized to 2 hour post prandial blood glucose monitoring

Trial Locations (1)

10021

New York Prebyterian Hospital Weill Cornell, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER